ZIOPHARM Oncology, Inc. carries a market capitalization of 208.12M, placing it among publicly traded companies globally.
| Market Cap | 208.12M |
| Enterprise Value | N/A |
ZIOPHARM Oncology, Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 1.07, while the 200-day moving average is 1.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.89 |
| Average Volume (20 Days) | N/A |
ZIOPHARM Oncology, Inc.'s most recent stock split took place on August 24, 2005 with a 40:1 split ratio.
| Last Split Date | 8/24/2005 |
| Split Ratio | 40:1 |